Gain Therapeutics, Inc.

As of June 20, 2025, the technical trend is bearish with moderate strength, driven by bearish signals from the weekly MACD and Bollinger Bands, daily moving averages, and a lack of upward momentum, despite some mixed monthly indicators.

Gain Therapeutics, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net loss of $5 million and a market cap of $51.21 million. Key financial metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -362.08%.

As of Jun 18, Gain Therapeutics, Inc. has a market capitalization of 51.21 million, with net sales of 0.00 million and a net profit of -20.93 million over the latest four quarters. The company reported shareholder's funds of 7.34 million and total assets of 12.12 million as of Dec 24.